Reactive oxygen and nitrogen species are generated by several inflammatory
and structural cells of the airways. These oxidant species have important e
ffects on a variety of lung cells as regulators of signal transduction, act
ivators of key transcription factors and modulators of gene expression and
apoptosis. Thus, increased oxidative stress accompanied by reduced endogeno
us antioxidant defenses may play a role in the pathogenesis of a number of
inflammatory pulmonary diseases, including respiratory distress syndrome (R
DS) in the newborn. There obviously are conflicting reports on the effect o
f oxygen, ventilation and nitric oxide (NO) on RDS and, thus, the question
arises as what the neonatologist should do when confronted with a newborn w
ith RDS. Clearly, utilizing lung protective strategies requires compromises
between gas exchange goals and potential toxicities associated with over-d
istension, derecruitment of lung units and high oxygen concentrations. The
results discussed in this brief review suggest rigorous clinical tests with
antioxidants which may help to define the mechanisms associated with RDS a
nd which could lead to new treatment strategies.